FDA Adverse Event Malfunction Summary report: N

LVP PRIMARY ADMIN 2-SET INLET

MDR report key: 19279420 · Received May 9, 2024

Report

Report Number
3014732157-2024-00217
Event Type
Malfunction
Date Received
May 9, 2024
Date of Event
April 22, 2024
Report Date
August 15, 2024
Manufacturer
FRESENIUS KABI USA, LLC
Product Code
FPA
PMA / PMN Number
K183311
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
ID, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Description of Event or Problem · 0

THE FOLLOWING HAS BEEN REPORTED: 4/22/2024 4:39 PM BY RISK,RDE WHEN ATTEMPTING TO START PT'S CHEMOTHERAPY, THE PRIMARY TUBING ON LOT NUMBER FA23E22360 HAD AN ISSUE WITH THE Y SITE, WHERE THE CHEMO SET WAS ATTACHED. IT SAID IT WAS OCCLUDED. I HAD TO PRIME A NEW PRIMARY TUBING AND ATTACH THE CHEMO TO THAT SET INSTEAD, USING ALL NEW TUBING AND A NEW EQUISHIELD. SECONF OCCURANCE REPORTED BY CUSTOMER. AN ACTIVE INFUSION WAS STOPPED. REPORTING AS A CONSERVATIVE MEASURE. NO ADVERSE EFFECTS WERE REPORTED. ADDITIONAL INFORMATION IS NEEDED TO COMPLETE THE INVESTIGATION.

Description of Event or Problem · 0

NO SAMPLE OR PICTURE WAS AVAILABLE FOR ANALYSIS. THEREFORE, THE CUSTOMER COMPLAINT CANNOT BE CONFIRMED AND A DEFINITIVE ROOT CAUSE CANNOT BE IDENTIFIED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1331133 LVP PRIMARY ADMIN 2-SET INLET ADMINISTRATION SET, PRODUCT FPA FRESENIUS KABI USA, LLC FA23E22360

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown